throbber
Case 1:17-cv-01790-GMS Document 4 Filed 12/12/17 Page 1 of 3 PagelD #: 230
`
`A0 12(2- (Rev. 08/10)
`
`TO :
`
`1111111 Step 3
`Director ei‘the H.231 Patent and Trademark Office
`Poi}. Box 1451.3
`Aiexandria, VA 2231341159
`
`TRADEMARK
`
`1112130111“ 0N 11111:
`FILING 0R DETERMINATIGN OF AN
`ACTIGN REGARDING A PATENT (IR
`
`in Campiianee with 35 USC. § 290 and/er 15 U.S.C. § 1116 you are hereby advised that 31 601111 action has been
`
`10111163 District 01 Deiawa re
`
`’11edinthe US. D1str1ct Court
`
`01] the feliewiiig
`
`E] 'E‘i‘ademarks (11'
`
`Mi’ziteths.
`
`( Z the patent ache-11 involves 35 USE. § 292.):
`
`DOCKET NO.
`
`DATE FILED
`
`US. DISTRICT COURT
`
`PLAINTIFF
`TEVA PHARMACEUTICALS ENTERNATEONAL GMBH,
`e1 1311.
`
`3
`
`DEFENDANI
`MYLAN LABORATORIES LEMETED
`
`13/12/2917
`
`.
`
`forthe District of Deiaware
`
`PATENT OR
`TRADEMARK NO
`
`DATE OF PATENT
`OR TRADEMARK
`
`,
`r
`.
`,‘ T ,_ T
`W
`1,
`,
`“KERR 0L P53“ OR TRAJEM‘
`
`«121"
`
`1 US 8,599 707 B2
`
`12/1 "Ii/2013
`
`Eagie Pharmaceuticaie, inc.
`
`2 US 8 791,270 82
`
`7/29/2014
`
`Cephaion, fine.
`
`3 US 9,000,021 B2
`
`4/7/2015
`
`Eagie Pharmaceutieais, inc.
`
`4 US 9,034,908 BE
`
`5/19/2015
`
`Eagie Pharmaceutieais, inc.
`
`5 US 9,144,568 B1
`
`9/29/2915
`
`Eagie Pharmaceutieais, inc.
`
`DATE INCLUDED
`
`In the above—entitled case, the following pate11t(s)/ trademarfls) have been inniuded:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`: Amehdment
`DATE OF FATE NT
`OR TRADEMARK
`
`[3 Answer
`
`[1 Cress; Bill
`
`[:1 Other Pieaehhg
`
`Y
`
`$7
`
`17
`
`\T‘J‘
`
`.
`
`r
`
`1 ARI”
`
`
`AOLDuR 0L Ph‘ERT OR TRA‘JEM‘
`(BY) DEPUTY CLERK
`
`[11 the abeve -----eht1tied case, the feiiewiiig deciswn has been rehdered erjudgement issued:
`DECISION/JUDG EEIENT
`
`Copy Inn-Upon initiation (11" action, maii this copy to Director Cepy 3------ Igioh termination of aei'ien, mzaii this (:(ipy te Iiirecthr
`Copy 2------Upon filing decoment adding patenfls), maii this ehpy th Director Cepy 1------Cause fiie (:(ipy
`
`

`

`Case 1:17-cv-01790-GMS Document 4 Filed 12/12/17 Page 2 of 3 PagelD #: 231
`
`A0 12(2- (Rev. 08/10)
`
`TO :
`
`111111151911 3
`Director ei‘the H.231 Patent and Trademark Office
`Poi}. Box 1451.3
`Aiexandrie, VA 22313411511
`
`TRADEMARK
`
`1112130111“ 0N 11111:
`FILING 0R DETERMINATIGN OF AN
`ACTIGN REGARDING A PATENT (IR
`
`in Campiianee with 35 USC. § 291'} and/er 15 U.S.C. § 1116 you are hereby advised that a unit action has been
`
`10111163 {31511161 01 Deiawa re
`
`’11edinthe US. D1str1ct Court
`
`01] the feliewiiig
`
`E] 'E‘i'ademarks (11'
`
`5513211621115.
`
`( Z the patent ache-11 involves 35 USE. § 292.):
`
`DOCKET NO.
`
`DATE FILED
`
`US. DISTRICT COURT
`
`PLAINTIFF
`TEVA PHARMACEUTICALS ENTERNATEONAL GMBH,
`e1 1311.
`
`3
`
`DEFENDANI
`MYLAN LABORATORIES LEMETED
`
`13/12/2917
`
`.
`
`forthe Dis1rie1 of Deiaware
`
`PATENT OR
`TRADEMARK NO
`
`DATE OF PATENT
`OR TRADEMARK
`
`‘
`r
`.
`,‘ T M T
`W
`W
`1
`“KERR 01 P53“ OR TRAJEM‘
`
`«121"
`
`1 US 9,265 831 B2
`
`2/23/2016
`
`Eagie Pharmaceuticaie, inc.
`
`2 US 9 572,296 82
`
`2/21/2017
`
`Eagle Pharmaceuiieais, inc.
`
`3 US 9,5?2,797 B2
`
`2/21/2917
`
`Eagie Pharmaceutieais, inc.
`
`4 US 9,572,881” B2
`
`2/21/2017
`
`Eagie Pharmaceutieais, inc.
`
`5 US 9,5?9,384 B2
`
`2/28/2917
`
`Eagie Pharmaceutieais, inc.
`
`DATE INCLUDED
`
`In the above—entitled case, the following pate11t(s),/’ trademarfls) have been inniuded:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`: Amehdment
`DATE OF FATE NT
`OR TRADEMARK
`
`[3 Answer
`
`[1 Cress; Bill
`
`[:1 Other Pieaehhg
`
`Y
`
`$7
`
`17
`
`\T‘J‘
`
`.
`
`r
`
`1 ARI”
`
`
`AOLDuR 0L Ph‘ERT OR TRA‘JEM‘
`(BY) DEPUTY CLERK
`
`[11 the abeve -----emfiied case, the feiiewiiig deeiswn has been rehdered erjudgement issued:
`DECISION/JUDG EEIENT
`
`Copy Inn-Upon initiation (11" action, maii this copy to Director Cepy 3------ Igzoh termination of aei'ien, mzaii this cepy te Iiirecthr
`Copy 2------Upon filing decoment adding patenfls), maii this ehpy th Director Cepy '1------Cause fiie cepy
`
`

`

`Case 1:17-cv-01790-GMS Document 4 Filed 12/12/17 Page 3 of 3 PagelD #: 232
`
`A0 12(2- (Rev. 08/10)
`
`TO :
`
`111111511111 3
`Director 611111: US. P1119111 and Trademark Office
`I919. Box 1451.3
`AIexamIrie, VA 2231343159
`
`TRADEMARK
`
`1112130111“ (IN 11111:
`FILING 0R DETERMINATIGN OF AN
`ACTIGN REGARDING A PATENT (IR
`
`E11 Cemplianee with 35 USC § 290 and/er 15 U.S.C. § 1116 you are hereby advised that 31 601111 action has been
`
`10111163 District 01 Deiaware
`
`diedin 1he'J. SD1S1.1czt C011r1
`
`011 the fellewiilg
`
`E] 'E‘i‘adeanatks (11'
`
`MPaiems.
`
`( Z the patent ache-11 involves 35 USE; § 292.):
`
`DQCKET N0.
`
`DATE FILED
`
`US. DISTRICT COURT
`
`PLAINTIFF
`
`12/12/2017
`
`.
`
`DEFENDANT
`
`forthe DisIrieI of Deiaware
`
`TEVA PHARMACEUTICALS ENTERNATEONAL GMBH,
`e1 :11.
`
`3
`
`MYLAN LABORATORIES LIMITED
`
`PATENT OR
`TRADEMARK NO
`
`DATE OF PATENT
`OR TRADEMARK
`
`,
`r
`,
`,‘ T ,_ ,
`W
`W
`,
`“KERR 0L P53“ OR TRMEM‘
`
`«121'
`
`1 US 9,597,397 B2
`
`3/21/2017
`
`Eagie Pharmaceuticaie, inc.
`
`2 US 9 597, 398 82
`
`13/21/2017
`
`Eagle Pharmaceuticaie, fine.
`
`US 9 ,597’ ,399 82
`
`3/21/2917
`
`Eagie Pharmaceutieais inc
`AOLDuR 0L PHAERT OR TRA‘JEMARR
`(BY) DEPUTY CLERK
`
`DATE INCLUDED
`
`In the above—entitled case, 111:? following pate111{s)/'11ademrk(s) have been inniuded:
`INCLUDED BY
`
`PA’I‘BNT OR
`TRADEMARK NO.
`
`: Amehdment
`DATE OF FATE NT
`OR TRADEMARK
`
`[3 Answer
`1
`
`$7
`
`[1 Cress; Bill
`17
`‘\ T 1 , T‘
`
`[:1 O1herPieaei1hg
`r
`1
`‘\
`1"
`
`1
`
`[11 the abeve -----e111111ed case, the fellewing (1121;511:1115 been rendered erjudgemem issued:
`DECISION/JUDG ELIENT
`
`Copy 1-----Upen initiation (11216111311, mail this eepy 11) Diree‘ter Cepy 3------ 151011 termination 01211111111, mzaii this cepy 1:11 Iiirecter
`{fem 2------Upon filing dewment adding patenfls), maifl this eepy 1:3 flireeter Cepy 4------Cause file cepy
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket